Thomas M. Ross - Mar 15, 2024 Form 4 Insider Report for MAXCYTE, INC. (MXCT)

Role: EVP, GLOBAL SALES & MARKETING
Signature: /s/ Katie Kazem, Attorney-in-Fact
Stock symbol: MXCT
Transactions as of: Mar 15, 2024
Transactions value $: $0
Form type: 4
Date filed: 3/19/2024, 06:21 PM
Previous filing: Apr 12, 2023
Next filing: Jun 24, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MXCT	Common Stock	Award	$0	+25K		$0.00	25K	Mar 15, 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MXCT	Employee Stock Option (right to buy)	Award	$0	+100K		$0.00	100K	Mar 15, 2024	Common Stock	100K	$4.31	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Twenty-five percent (25%) of the RSUs shall vest on March 15, 2025, and the remainder shall vest in three (3) equal annual installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.
F2	Twenty-five percent (25%) of the shares underlying this option shall vest on March 15, 2025, and the remainder shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.